Skip to main content
Signal8

Scholl Hendrik Peter

SEC insider (Form 3/4/5 filer). CIK 0002113223. Chief Medical Officer at BELITE BIO, INC (BLTE). 22 reported Form 4/5 transactions since Sep 2024; latest on Oct 1, 2026. Located in ZUG.

Companies Scholl Hendrik Peter has filed insider reports for

  • BELITE BIO, INC (BLTE): Officer, Chief Medical Officer
Scholl Hendrik Peter profile photo

Scholl Hendrik Peter

CIK: 0002113223

Transaction Breakdown

Open Market Buys (P)0 (0.0%)

High conviction signal

Open Market Sales (S)21 (95.5%)

Position reduction

Option Exercises (M)0 (0.0%)

Derivative conversions

Awards (A)0 (0.0%)

Compensation grants

Other (G, F, J, C, D, …)1 (4.5%)

Gifts, tax withholding, conversions, dispositions to the issuer and other codes

Companies & Roles (1)

BELITE BIO, INC logo
BLTE

BELITE BIO, INC

Officer

Discretionary Trading P&L

Holdings

Transaction History (22 total)

  • BELITE BIO, INC logo
    BLTE

    BELITE BIO, INC

    Oct 1, 2026
    Sale
    Indirect
    78 shares at avg. $167.59$13K
  • BELITE BIO, INC logo
    BLTE

    BELITE BIO, INC

    Oct 1, 2026
    Sale
    Indirect
    120 shares at avg. $165.49$20K
  • BELITE BIO, INC logo
    BLTE

    BELITE BIO, INC

    Oct 1, 2026
    Sale
    Indirect
    24 shares at avg. $164.64$4K
  • BELITE BIO, INC logo
    BLTE

    BELITE BIO, INC

    Oct 1, 2026
    Sale
    Indirect
    200 shares at avg. $163.63$33K
  • BELITE BIO, INC logo
    BLTE

    BELITE BIO, INC

    Oct 1, 2026
    Sale
    Indirect
    12 shares at avg. $168.21$2K
  • BELITE BIO, INC logo
    BLTE

    BELITE BIO, INC

    Oct 1, 2026
    Sale
    Indirect
    14 shares at avg. $169.36$2K
  • BELITE BIO, INC logo
    BLTE

    BELITE BIO, INC

    Oct 1, 2026
    Sale
    Indirect
    2 shares at avg. $170.02$340.04
  • BELITE BIO, INC logo
    BLTE

    BELITE BIO, INC

    Oct 1, 2026
    Sale
    Indirect
    50 shares at avg. $166.44$8K
  • BELITE BIO, INC logo
    BLTE

    BELITE BIO, INC

    Jun 18, 2026
    Sale
    Indirect
    96 shares at avg. $143.90$14K
  • BELITE BIO, INC logo
    BLTE

    BELITE BIO, INC

    Jun 18, 2026
    Sale
    Indirect
    3.7K shares at avg. $144.66$542K

1-10 of 22